January 14, 2009 – A published report of a meta-analysis by Thad Wilkins, M.D., et al.

January 14, 2009 - Merit Medical Systems Inc. said today that it will enter the microcatheter market with the release of the recently FDA cleared Merit Maestro Microcatheter. Microcatheters are used to deliver various diagnostic, embolic and therapeutic materials to treat uterine fibroids, hypervascularized tumors and vascular malformations.

January 13, 2009 — Tawam Hospital, a leading medical institution in the Middle East, went live with Philips Healthcare’s new iSite Picture Archiving and Communication System (PACS), representing the first public hospital in the Middle East to implement iSite’s ‘fee per study’ model.

January 13, 2009 - Vital Images Inc. and Toshiba Medical Systems Corp. have agreed to co-develop and collaborate on a joint investment to develop and deliver innovative technology advancements for Toshiba's modalities, including the Aquilion ONE CT scanner, and Vital Images' advanced visualization software solutions.

January 12, 2009 - Varian Medical Systems said it estimates it will report net orders growth of 12-13 percent in the first quarter of fiscal year 2009 over the period last year with gains in all of its major businesses.

January 12, 2009 - The Centers for Medicare and Medicaid Services (CMS) released a draft of their proposed positron emission tomography (PET) national coverage determination (NCD) to allow for reimbursement of PET by the federal government for patients with all types of cancer.

January 9, 2009 - The 2009 Spring Radiology & Imaging Conference will be held May 6-8, 2009 at the Hyatt Regency in Miami, FL. To receive “early bird pricing,” participants must register by Friday, Jan. 30 at www.hlthcp.com.

January 8, 2009 - Two RSNA exhibits featuring Aquarius iNtuition by TeraRecon won Cum Laude awards at the recent 94th annual Radiological Society of North America (RSNA) Scientific Assembly at McCormick Place in Chicago, IL, Nov. 30 - Dec. 5, 2008.

January 8, 2009 - A newly identified gene, called metadherin, might cause breast cancer tumors to spread and become resistant to chemotherapy, according to a study published in the journal Cancer Cell.

January 8, 2009 – Bayer Schering Pharma AG and Hamamatsu Photonics K.K., Japan have signed a licensing agreement for the use of novel substances in the field of molecular imaging for cancer, allowing the company to expand its existing molecular imaging portfolio in the area of cancer.